ArticleJournal for immunotherapy of cancer2021

Nanoencapsulated rituximab mediates superior cellular immunity against metastatic B-cell lymphoma in a complement competent humanized mouse model.

Jing Wen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.